The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
Open accessAbstract
The effectiveness of antimuscarinic agents in the treatment of the overactive bladder (OAB) syndrome is thought to arise through blockade of bladder muscarinic receptors located on detrusor smooth muscle cells, as well as on nondetrusor structures. Muscarinic M 3 receptors are primarily responsible for detrusor contraction. Limited evidence exists to suggest that M 2 receptors may have a role in mediating indirect contractions and/or inhibition of detrusor relaxation. In addition, there is evidence that muscarinic receptors located in the urothelium/suburothelium and on afferent nerves may contribute to the pathophysiology of OAB. Blockade of these receptors may also contribute to the clinical efficacy of antimuscarinic agents. Although the role of muscarinic receptors in the bladder, other than M 3 receptors, remains unclear, their role in other body systems is becoming increasingly well established, with emerging evidence supporting a wide range of diverse functions. Blockade of these functions by muscarinic receptor antagonists can lead to similarly diverse adverse effects associated with antimuscarinic treatment, with the range of effects observed varying according to the different receptor subtypes affected. This review explores the evolving understanding of muscarinic receptor functions throughout the body, with particular focus on the bladder, gastrointestinal tract, eye, heart, brain and salivary glands, and the implications for drugs used to treat OAB. The key factors that might determine the ideal antimuscarinic drug for treatment of OAB are also discussed. Further research is needed to show whether the M 3 selective receptor antagonists have any advantage over less selective drugs, in leading to fewer adverse events. British Journal of Pharmacology(2006)148, 565–578. doi:10.1038/sj.bjp.0706780
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., van Kerrebroeck, P., Victor, A., & Wein, A. (2002) · Neurourology and Urodynamics · doi:10.1002/nau.10052 · Cited by 8,296
Self-citationA systematic review of the associations between dose regimens and medication compliance
Claxton, A. J., Cramer, J., & Pierce, C. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80109-0 · Cited by 2,388
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Hulme, E. C., Birdsall, N. J. M., & Buckley, N. J. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.003221 · Cited by 1,338
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 692
A neurologic basis for the overactive bladder
de Groat, W. C. (1997) · Urology · doi:10.1016/s0090-4295(97)00587-6 · Cited by 596
Self-citationSelective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice
Anagnostaras, S. G., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama, N. P., Nathanson, N. M., & Silva, A. J. (2003) · Nature Neuroscience · doi:10.1038/nn992 · Cited by 544
Self-citationMatsui, M., Motomura, D., Karasawa, H., Fujikawa, T., Jiang, J., Komiya, Y., Takahashi, S.-I., & Taketo, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9579 · Cited by 450
Starr, J. M. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.70 · Cited by 434
Antimuscarinics for treatment of overactive bladder
Andersson, K.-E. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00622-7 · Cited by 414
Self-citationAnticholinergic effects of medication in elderly patients.
Tune, L. E. (2001) · PubMed · Cited by 400
Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean
Yamada, M., Miyakawa, T., Duttaroy, A., Yamanaka, A., Moriguchi, T., Makita, R., Ogawa, M., Chou, C. J., Xia, B., Crawley, J. N., et al. (2001) · Nature · doi:10.1038/35065604 · Cited by 373
Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice
Gomeza, J., Shannon, H., Kostenis, E., Felder, C., Zhang, L., Brodkin, J., Grinberg, A., Sheng, H., & Wess, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1692 · Cited by 348
Esposito, P., Gheorghe, D., Kandere, K., Pang, X., Connolly, R., Jacobson, S., & Theoharides, T. C. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03026-2 · Cited by 333
Principles of Saliva Secretion
BAUM, B. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb18338.x · Cited by 314
Hegde, S. S., Choppin, A., Bonhaus, D., Briaud, S., Loeb, M., Moy, T. M., Loury, D., & Eglen, R. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701048 · Cited by 300
Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus
Volpicelli, L. A., & Levey, A. I. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45003-6 · Cited by 298
ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCE
ANDERSON, R. U., MOBLEY, D., BLANK, B., SALTZSTEIN, D., SUSSET, J., & BROWN, J. S. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68810-6 · Cited by 286
Antimuscarinics and the Overactive Detrusor—Which Is the Main Mechanism of Action?
Andersson, K.-E., & Yoshida, M. (2003) · European Urology · doi:10.1016/s0302-2838(02)00540-7 · Cited by 284
Self-citationYamada, M., Lamping, K. G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F. P., McKinzie, D. L., Felder, C. C., Deng, C.-X., Faraci, F. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251542998 · Cited by 275
The impact of reducing dose frequency on health outcomes
Richter, A., Anton, S. E., Koch, P., & Dennett, S. L. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80222-9 · Cited by 271
Muscarinic receptors in the Mammalian Heart
Dhein, S., van Koppen, C. J., & Brodde, O.-E. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0835 · Cited by 263
Katz, I. R., Sands, L. P., Bilker, W., DiFilippo, S., Boyce, A., & D'Angelo, K. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb01006.x · Cited by 256
Drug delivery to the retina: challenges and opportunities
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.45 · Cited by 249
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs
Perry, E. K., Kilford, L., Lees, A. J., Burn, D. J., & Perry, R. H. (2003) · Annals of Neurology · doi:10.1002/ana.10639 · Cited by 231
Seeger, T., Fedorova, I., Zheng, F., Miyakawa, T., Koustova, E., Gomeza, J., Basile, A. S., Alzheimer, C., & Wess, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3581-04.2004 · Cited by 214
Matsui, M., Motomura, D., Fujikawa, T., Jiang, J., Takahashi, S.-I., Manabe, T., & Taketo, M. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10627.2002 · Cited by 213
Ikeda, K., Kobayashi, S., Suzuki, M., Miyata, K., Takeuchi, M., Yamada, T., & Honda, K. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0554-x · Cited by 199
M2 and M4 Receptor Knockout Mice: Muscarinic Receptor Function in Cardiac and Smooth Muscle In Vitro
Stengel, P. W., Gomeza, J., Wess, J., & Cohen, M. L. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35366-2 · Cited by 190
The minor population of M3‐receptors mediate contraction of human detrusor muscle in vitro
Chess‐Williams, R., Chapple, C. R., Yamanishi, T., Yasuda, K., & Sellers, D. J. (2001) · Journal of Autonomic Pharmacology · doi:10.1046/j.1365-2680.2001.00231.x · Cited by 179
Self-citationASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF DARIFENACIN
LIPTON, R. B., KOLODNER, K., & WESNES, K. (2005) · Journal of Urology · doi:10.1097/01.ju.0000148963.21096.5d · Cited by 179
Fisher, A., Pittel, Z., Haring, R., Bar-Ner, N., Kliger-Spatz, M., Natan, N., Egozi, I., Sonego, H., Marcovitch, I., & Brandeis, R. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:349 · Cited by 173
Bymaster, F. P., Carter, P. A., Yamada, M., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., McKinzie, D. L., & Felder, C. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02588.x · Cited by 167
Self-citationTzavara, E. T., Bymaster, F. P., Felder, C. C., Wade, M., Gomeza, J., Wess, J., McKinzie, D. L., & Nomikos, G. G. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001270 · Cited by 163
Gautam, D., Heard, T. S., Cui, Y., Miller, G., Bloodworth, L. M., & Wess, J. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.260 · Cited by 155
Gupta, S., & Sathyan, G. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/009127009903900313 · Cited by 155
Abdel-Rahman, A. A., Shetty, A. K., & Abou-Donia, M. B. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0524 · Cited by 142
Chapple, C. R., Steers, W. D., Norton, P., Millard, R. J., Kralidis, G., Glavind, K., & Abrams, P. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05454.x · Cited by 133
Self-citationDeterminants of Passive Drug Entry into the Central Nervous System
Habgood, M. D., Begley, D. J., & Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007001923498 · Cited by 131
Stengel, P. W., Yamada, M., Wess, J., & Cohen, M. L. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00486.2001 · Cited by 129
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers
Pietzko, A., Dimpfel, W., Schwantes, U., & Topfmeier, P. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00191165 · Cited by 114
Tolterodine and Memory: Dry but Forgetful
Womack, K. B., & Heilman, K. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.771 · Cited by 104
Muscarinic receptors and gastrointestinal tract smooth muscle function
Eglen, R. M. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01054-2 · Cited by 102
Evidence for a preferential involvement of M1 muscarinic receptors in representational memory
Messer, W. S., Bohnett, M., & Stibbe, J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90407-z · Cited by 94
Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon
Li, M., Johnson, C. P., Adams, M. B., & Sarna, S. K. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00114.2001 · Cited by 87
Olsson, B., & Szamosi, J. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140030-00006 · Cited by 85
Serotonin and its implication for the management of irritable bowel syndrome.
Gershon (2003) · PubMed · Cited by 81
Gillberg, P., Sundquist, S., & Nilvebrant, L. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00214-3 · Cited by 78
Collison, D. J., Coleman, R. A., James, R. S., Carey, J. E., & Duncan, G. (2000) · PubMed · Cited by 76
Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier.
Pakulski, C., Drobnik, L., & Millo, B. (2000) · PubMed · Cited by 70
Muscarinic (M) Receptors in Coronary Circulation
Lamping, K. G., Wess, J., Cui, Y., Nuno, D. W., & Faraci, F. M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000130661.82773.ca · Cited by 65
Kay, G. G., & Wesnes, K. A. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05745.x · Cited by 64
Self-citationDiefenbach, K., Donath, F., Maurer, A., Quispe-Bravo, S., Wernecke, K., Schwantes, U., Haselmann, J., & Roots, I. (2003) · Clinical Drug Investigation · doi:10.2165/00044011-200323060-00003 · Cited by 63
Serra, D. B., Affrime, M. B., Bedigian, M. P., Greig, G., Milosavljev, S., Skerjanec, A., & Wang, Y. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005279010 · Cited by 56
Both M1 and M3 receptors regulate exocrine secretion by mucous acini
Culp, D. J., Luo, W., Richardson, L., Watson, G. E., & Latchney, L. R. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.6.c1963 · Cited by 55
Identification of muscarinic receptor subtypes in mouse parotid gland
Watson, E. L., Abel, P. W., DiJulio, D. H., Zeng, W., Makoid, M. C., Jacobson, K. L., Potter, L. T., & Dowd, F. J. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.3.c905 · Cited by 54
WoldeMussie, E., Feldmann, B., & Chen, J. (1993) · Experimental Eye Research · doi:10.1006/exer.1993.1052 · Cited by 52
Demonstration of functional M3‐muscarinic receptors in ventricular cardiomyocytes of adult rats
Pönicke, K., Heinroth‐Hoffmann, I., & Brodde, O. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704997 · Cited by 52
Altered Cardiovascular Responses in Mice Lacking the M1 Muscarinic Acetylcholine Receptor
Hardouin, S. N., Richmond, K. N., Zimmerman, A., Hamilton, S. E., Feigl, E. O., & Nathanson, N. M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.129 · Cited by 43
Self-citationChiba, T., Bharucha, A. E., Thomforde, G. M., Kost, L. J., & Phillips, S. F. (2002) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2002.00357.x · Cited by 41
Colecraft, H. M., Egamino, J. P., Sharma, V. K., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32158 · Cited by 41
Existence of functional M 3 -muscarinic receptors in the human heart
Willmy-Matthes, P., Leineweber, K., Wangemann, T., Silber, R.-E., & Brodde, O. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0796-2 · Cited by 40
Blood-CSF barrier integrity in multiple sclerosis
Liebsch, R., Kornhuber, M. E., Dietl, D., Einsiedel, H. G., & Conrad, B. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00052.x · Cited by 33
Zhou, H., Meyer, A., Starke, K., Gomeza, J., Wess, J., & Trendelenburg, A. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-001-0517-7 · Cited by 28
Tobin, G. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(02)00094-2 · Cited by 19
Cited by
Chapple, C. R., Khullar, V., Gabriel, Z., Muston, D., Bitoun, C. E., & Weinstein, D. (2008) · European Urology · doi:10.1016/j.eururo.2008.06.047 · Cited by 769
Self-citationMuscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Gender and incidence of dementia in the Framingham Heart Study from mid‐adult life
Chêne, G., Beiser, A., Au, R., Preis, S. R., Wolf, P. A., Dufouil, C., & Seshadri, S. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.005 · Cited by 499
Chughtai, B., Forde, J. C., Thomas, D. D. M., Laor, L., Hossack, T., Woo, H. H., Te, A. E., & Kaplan, S. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.31 · Cited by 462
Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration
Sorrentino, G., Perino, A., Yildiz, E., El Alam, G., Bou Sleiman, M., Gioiello, A., Pellicciari, R., & Schoonjans, K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.067 · Cited by 399
Metadata
- Authors
- Abrams, P., Andersson, K., Buccafusco, J. J., Chapple, C., de Groat, W. C., Fryer, A. D., Kay, G., Laties, A., Nathanson, N. M., Pasricha, P. J., & Wein, A. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-07
- Volume
- 148
- Issue
- 5
- Pages
- 565-578
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2105391780
- Cited by
- 632
- References
- 69
- FWCI
- 30.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.